Moreover, a nonparametric test was also performed in PCa samples to analyze the probability of being classify as cancer cases based on the variation of the PCa-selected circulating-miRNA depending on Gleason Score (GS) and prostate specific antigen (PSA) values. The gene discussed is KLK3; the disease is posterior cortical atrophy.